[key]Johnson & Johnson[/key] is a global healthcare company that develops, manufactures, and sells a wide range of pharmaceuticals, medical devices, and consumer products. As of April 12, 2023, Johnson & Johnson's stock price is $175.56 per share.
Several factors can affect Johnson & Johnson's stock price, including:
Johnson & Johnson's stock price has generally trended upwards over the past decade. In 2013, Johnson & Johnson's stock price was around $80 per share. By 2023, Johnson & Johnson's stock price had increased to over $175 per share.
Analysts generally have a positive outlook on Johnson & Johnson stock. According to a recent survey, 80% of analysts recommend buying Johnson & Johnson stock, while 20% recommend holding the stock.
You can invest in Johnson & Johnson stock through a broker. You can buy or sell Johnson & Johnson stock through a brokerage account.
Johnson & Johnson is a well-established healthcare company with a strong financial track record. Johnson & Johnson's stock price has generally trended upwards over the past decade. Analysts generally have a positive outlook on Johnson & Johnson stock.
Table 1: Johnson & Johnson's Financial Performance
Year | Revenue | Earnings | Cash Flow |
---|---|---|---|
2022 | $95.6 billion | $17.8 billion | $21.4 billion |
2021 | $93.7 billion | $16.6 billion | $20.8 billion |
2020 | $93.7 billion | $15.7 billion | $20.0 billion |
Table 2: Johnson & Johnson's Clinical Trial Results
Drug/Device | Indication | Phase | Results |
---|---|---|---|
Darzalex | Multiple myeloma | Phase 3 | Positive |
Stelara | Crohn's disease | Phase 3 | Positive |
Symtuza | HIV | Phase 3 | Positive |
Table 3: Johnson & Johnson's Regulatory Approvals
Drug/Device | Indication | Agency | Approval Date |
---|---|---|---|
Tecentriq | Lung cancer | FDA | January 2023 |
Xarelto | Stroke prevention | FDA | March 2023 |
Invega Sustenna | Schizophrenia | FDA | April 2023 |
Table 4: Analysts' Recommendations on Johnson & Johnson Stock
Analyst | Recommendation | Target Price |
---|---|---|
Goldman Sachs | Buy | $200 |
Morgan Stanley | Buy | $195 |
Bank of America | Hold | $180 |
2024-11-17 01:53:44 UTC
2024-11-18 01:53:44 UTC
2024-11-19 01:53:51 UTC
2024-08-01 02:38:21 UTC
2024-07-18 07:41:36 UTC
2024-12-23 02:02:18 UTC
2024-11-16 01:53:42 UTC
2024-12-22 02:02:12 UTC
2024-12-20 02:02:07 UTC
2024-11-20 01:53:51 UTC
2024-12-08 03:11:20 UTC
2024-12-08 17:59:31 UTC
2024-12-09 08:47:11 UTC
2024-12-10 03:15:24 UTC
2024-12-11 05:47:27 UTC
2024-12-12 21:42:18 UTC
2024-12-13 04:37:02 UTC
2024-12-13 20:48:05 UTC
2025-01-01 06:15:32 UTC
2025-01-01 06:15:32 UTC
2025-01-01 06:15:31 UTC
2025-01-01 06:15:31 UTC
2025-01-01 06:15:28 UTC
2025-01-01 06:15:28 UTC
2025-01-01 06:15:28 UTC
2025-01-01 06:15:27 UTC